^
Association details:
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
New
Title:

A phase II trial of dasatinib in advanced melanoma

Excerpt:
Only one responder, a patient with a primary subungual melanoma, had a K642E substitution mutation in exon 13 of c-kit.
DOI:
10.1002/cncr.25766